Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$85,478,682
+$3,051,070 QoQ
Shares Held
336,570
-0.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#332
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2023CallValue
$13,241,600
CallShares
80,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $338,415,690 across 14 Drug Manufacturers - General names. JNJ ranks #1 (25.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
336,570 | $85,478,682 | |
| 2 | LLY |
ELI LILLY & Co
|
59,006 | $70,773,572 | |
| 3 | ABBV |
AbbVie Inc.
|
190,827 | $48,019,706 | |
| 4 | MRK |
Merck & Co., Inc.
|
271,475 | $34,884,537 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
417,663 | $24,065,742 | |
| 6 | AMGN |
Amgen Inc
|
47,883 | $17,339,391 | |
| 7 | NVS |
Novartis AG
|
104,792 | $16,423,002 | |
| 8 | PFE |
Pfizer Inc
|
634,638 | $15,282,083 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,478,682 | 336,570 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $82,427,612 | 337,210 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $74,987,711 | 362,347 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,450,263 | 358,377 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $54,119,019 | 354,298 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $64,783,737 | 390,640 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $58,464,081 | 404,260 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $90,494,141 | 558,399 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $80,530,944 | 550,978 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $78,482,804 | 496,130 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $65,606,818 | 418,571 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $69,631,308 | 447,071 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $13,241,600 | 80,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $68,995,025 | 416,838 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,969,555 | 109,481 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,243,014 | 108,933 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,802,482 | 108,977 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,092,448 | 118,824 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,959,465 | 112,619 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $22,074,188 | 129,036 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $19,601,416 | 121,371 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,728,330 | 107,614 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $17,483,553 | 106,380 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,264,765 | 90,639 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $14,493,021 | 97,347 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $13,547,450 | 96,334 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $9,380,122 | 71,533 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||